Once-daily dosing of insulin detemir is associated with lower risk of hypoglycaemia at similar levels of HbA(1c) compared to once-daily NPH insulin in subjects with type 1 diabetes mellitus
conference contribution
posted on 2023-02-07, 23:58authored byJE Shaw, J Larsen, CB Pedersen, S Tang-Fui
Once-daily dosing of insulin detemir is associated with lower risk of hypoglycaemia at similar levels of HbA(1c) compared to once-daily NPH insulin in subjects with type 1 diabetes mellitus